期刊文献+

1例乳腺癌患者手术及化疗期间的药学监护 被引量:3

Pharmaceutical care of one patient with breast cancer during operation and chemotherapy
下载PDF
导出
摘要 目的说明如何对老年合并高血压的乳腺癌患者进行药学监护及药学监护对患者的重要性。方法临床药师参与1例老年合并高血压的乳腺癌患者治疗过程,对患者进行药学监护,为临床提供合理化用药方案,即时处理用药后的不良反应。结果在临床药师的药学监护下,患者在围术期,抗菌使用合理,无切口感染;在化疗期,化疗药物安全使用,保证了手术和化疗的顺利进行。结论临床药师深入临床,参与药物治疗,不仅保证了临床用药的安全、有效,还为患者减轻了经济负担。 Objective To explain how to implement pharmaceutical care for elder patients with breast cancer complicated by hypertension and the importance of pharmaceutical care to patients.Methods The clinical pharmacists participated in the treatment course of one elder patient with breast cancer complicated by hypertension,provided pharmaceutical care for the patient,provided rationalized drug administration schedule and timely managed post-administration adverse reactions.Results Under the pharmaceutical care of the clinical pharmacists,in the perioperative period,the patient received reasonable antibiosis and had no wound infection,and in the chemotherapy period,the chemotherapy drugs were safely used,which ensured the smooth progress of surgery and chemotherapy.Conclusion The clinical pharmacists deeply involved in the clinical drug treatment not only ensure the safety and effectiveness of clinical medication,but also reduce the financial burden for patients.
作者 张鹏飞
出处 《中国医药导报》 CAS 2012年第6期103-104,共2页 China Medical Herald
关键词 乳腺癌 血压 药学监护 化疗 Breast cancer Blood pressure Pharmaceutical care Chemotherapy
  • 相关文献

参考文献5

  • 1吴在德 吴肇汉.外科学[M].北京:人民卫生出版社,2004.570.
  • 2卫生部办公厅.关于抗菌药物临床应用管理有关问题的通知[z].卫办医政发[2009]38号.
  • 3王玉洁,柴艳冬,戴晓雁,达超亮,严红艳,李世唐,吴海盼,张燕.多西他赛主要不良反应及处理对策[J].甘肃医药,2009,28(4):263-264. 被引量:4
  • 4陈新谦,金有豫,汤光.新编药物学[M].北京:人民卫生出版社,2011:609-621.
  • 5王庆利,彭健.吐温80的安全性研究进展[J].毒理学杂志,2006,20(4):262-264. 被引量:55

二级参考文献30

  • 1郝学志,张湘茹,孙燕,多西他赛临床研究协作组.国产多西他赛治疗乳腺癌和非小细胞肺癌的临床观察[J].中国肿瘤临床,2005,32(18):1064-1066. 被引量:24
  • 2惠双.多西紫杉醇致重度致死性水肿1例[J].中国煤炭工业医学杂志,2006,9(4):317-317. 被引量:5
  • 3何红梅,刘贤称.多西他赛不良反应观察及处理[J].交通医学,2006,20(5):616-616. 被引量:3
  • 4Daher CF,Baroody GM,Howland RJ.Effect of a surfactant,Tween 80,on the formation and secretion of chylomicrons in the rat.Food Chem Toxicol,2003,41:575-582.
  • 5Masini E,Planchenault J,Pezziardi F,et al.Histaminereleasing properties of Polysorbate 80 in vitro and in vivo:correlation with its hypotensive action in the dog.Agents Actions,1985,16:470-477.
  • 6Krantz JC,Carr CJ.Sugar alcoholsⅩⅩⅦ; drug allergy in the canine family.J Pharmacol Exp Ther,1949,97:125-128.
  • 7Krantz JC,Carr C J,Bird JG,et al.Sugar alcoholsⅩⅩⅥ;Pharmacodynamic Studies of Polyoxyalkylene Derivatives of Hexitol Anhydride Partial Fatty Acid Esters.J Pharmacol Exp Ther,1948,93:188-195.
  • 8Eschalier A,Lavarenne J,Burtin C,et al.Study of histamine release induced by acute administration of antitumor agents in dogs.Cancer Chem Pharmacol,1988,21:246-250.
  • 9Gough WB,Zeiler RH,Barreca P,et al.Hypotensive action of commercial intravenous amiodarone and polysorbate 80 in dogs.J Cardiovasc Pharmacol,1982,4:375-380.
  • 10Kellner A,Correll JW,Ladd AT.Sustained hyperlipemia induced in rabbits by means of intravenously injected surfaceactive agents.J Exp Med,1951,93:373-384.

共引文献541

同被引文献17

  • 1卫生部,国家食品药品监督管理局,国家中医药管理局.中药注射剂临床使用基本原则[S]. 2008-12-24.
  • 2El Weshi A, Tulbah A, A1 Sayed A, et al. Triple negative breast cancer. A clinicopathological study of 113 cases and comparison with 55 cases with triple positive breast cancer: A match control analysis I J]. J Clin Oncol,2007,25 (18S,Part I) :A21119.
  • 3Hayes DF, Thor AD, Dressier LG, et al. HER2 and response to paclitaxel in node-positive breast cancer[ J ]. N Engl J Med,2007,357 (5) : 1496 - 1506.
  • 4Badve S, Turbin D, Thoratl MA, et al. FOXA1 expression in breast canc- er-correlation with luminal subtype A and survival [ J ]. Clin Cancer Res,2007,13(15 Pt 1) :4415 -4421.
  • 5Carey LA, Dees EC, Sawye L, et al. The Triple Negative Paradox : Primary Tumor Chemosensitivity of Breast Cancer Subtypes [ J ]. Clin Cancer Res, 2007,13:2329 -2334.
  • 6Sofia B, Lissandra dL, Chantal B, et al. Use of trastuzumab for the treat- ment of early stage breast cancer [ J]. Expet Rev Anticancer Ther,2006, 6(8) :1153 - 1164.
  • 7Berry DA, Cirrincione C, Henderson IC, et al. Estrogen-receptor status and outcomes of modem chemotherapy for patients with node-positive breast cancer[ J]. JAMA ,2006,295 ( 14 ) : 1658 - 1667.
  • 8Frederique Penanh-Llorca, Fabrice Andre, Christine Sagan, et al. Ki67 Expression and Docetaxel Efficacy in Patients with Estrogen Receptor- Positive Breast Cancer[ J]. Journal of Clinical Oncology ,2009,27 ( 17 ) : 2809 - 2815.
  • 9药品不良反应报告和监测管理办法(中华人民共和国卫生部令第81号)2011年5月[S].
  • 10中华人民共和国卫生部令第8 1 号.药品不良反应报告和监测管理办法[S]. 2 0 1 1 -5 .

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部